Question 1

What is Marker Therapeutics Inc (MRKR) stock price today?

Accepted Answer

Marker Therapeutics Inc (MRKR) currently trades at $1.46 per share. The stock has a market capitalization of $24.18M and a P/E ratio of —x.

Question 2

Is MRKR stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Marker Therapeutics Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Marker Therapeutics Inc's revenue and earnings?

Accepted Answer

Marker Therapeutics Inc has trailing twelve-month (TTM) revenue of $3.55M with profit margins of 0.00%. Earnings per share (EPS) is $-0.79.

Question 4

Is MRKR stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Marker Therapeutics Inc's intrinsic value is $0.91, representing a margin of safety of -60.44%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$3.51M	$3.31M	$6.59M	$3.55M	$3.55M
Net income	$-29.93M	$-8.24M	$-10.73M	$-12.16M	$-1.70M
EPS	—	—	—	—	$-0.79
Free cash flow	$-26.97M	$-16.44M	$-10.91M	$-12.01T	$-12.01T
Profit margin	-851.87%	-248.76%	-162.82%	-342.96%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MRKR	$24.18M	24	3.3	2.5	4.0	5.0	-60.44%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Marker Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare